Pages with the fewest revisions

Jump to navigation Jump to search

Showing below up to 250 results in range #301 to #550.

View (previous 250 | next 250) (20 | 50 | 100 | 250 | 500)

  1. ICRP Publication 74‏‎ (1 revision)
  2. Sublethal damage repair‏‎ (1 revision)
  3. ICRP Publication 89‏‎ (1 revision)
  4. Exogenous excretion‏‎ (1 revision)
  5. 1931 Recommendations‏‎ (1 revision)
  6. Transfer of risk‏‎ (1 revision)
  7. Molecular imaging‏‎ (1 revision)
  8. Noise‏‎ (1 revision)
  9. Adenoma‏‎ (1 revision)
  10. ΓH2AX foci‏‎ (1 revision)
  11. Operating management‏‎ (1 revision)
  12. ICRP Publication 108‏‎ (1 revision)
  13. Brachytherapy‏‎ (1 revision)
  14. Quality control testing‏‎ (1 revision)
  15. ICRP Publication 121‏‎ (1 revision)
  16. Case–control study‏‎ (1 revision)
  17. Radioactive waste‏‎ (1 revision)
  18. ICRP Publication 136‏‎ (1 revision)
  19. Collective dose‏‎ (1 revision)
  20. ICRP Publication 150‏‎ (1 revision)
  21. ICRP Publication 25‏‎ (1 revision)
  22. ICRP Publication 31‏‎ (1 revision)
  23. Deterministic effect‏‎ (1 revision)
  24. Risk model‏‎ (1 revision)
  25. ICRP Publication 46‏‎ (1 revision)
  26. Sheltering‏‎ (1 revision)
  27. Induced genomic instability‏‎ (1 revision)
  28. ICRP Publication 60‏‎ (1 revision)
  29. Dose modifying factor‏‎ (1 revision)
  30. ICRP Publication 75‏‎ (1 revision)
  31. Licensee‏‎ (1 revision)
  32. ICRP Publication 9‏‎ (1 revision)
  33. Thermodynamic diameter‏‎ (1 revision)
  34. Low linear energy transfer radiation‏‎ (1 revision)
  35. 1934 Recommendations‏‎ (1 revision)
  36. Access control‏‎ (1 revision)
  37. Nominal risk coefficient‏‎ (1 revision)
  38. General Information: Radon‏‎ (1 revision - redirect page)
  39. Annual intake‏‎ (1 revision)
  40. ICRP Publication 109‏‎ (1 revision)
  41. ICRP Publication 122‏‎ (1 revision)
  42. ICRP Publication 137‏‎ (1 revision)
  43. ICRP Publication 151‏‎ (1 revision)
  44. ICRP Publication 26‏‎ (1 revision)
  45. DS86‏‎ (1 revision)
  46. ICRP Publication 32‏‎ (1 revision)
  47. ICRPædia Guide to Radiological Protection in Healthcare‏‎ (1 revision - redirect page)
  48. ICRP Publication 47‏‎ (1 revision)
  49. Shielding‏‎ (1 revision)
  50. ICRP Publication 61‏‎ (1 revision)
  51. ICRP Publication 76‏‎ (1 revision)
  52. Superposition principle‏‎ (1 revision)
  53. Life Span Study‏‎ (1 revision)
  54. Equilibrium equivalent concentration‏‎ (1 revision)
  55. Thoracic airways‏‎ (1 revision)
  56. Expanded radiation field‏‎ (1 revision)
  57. 1937 Recommendations‏‎ (1 revision)
  58. Multifactorial diseases‏‎ (1 revision)
  59. Nominal value‏‎ (1 revision)
  60. Adventitious source‏‎ (1 revision)
  61. Optimisation of protection‏‎ (1 revision)
  62. Backscatter factor‏‎ (1 revision)
  63. ICRP Publication 10A‏‎ (1 revision)
  64. Quasi-threshold dose‏‎ (1 revision)
  65. ICRP Publication 123‏‎ (1 revision)
  66. Charged-particle equilibrium‏‎ (1 revision)
  67. ICRP Publication 138‏‎ (1 revision)
  68. Collimation‏‎ (1 revision)
  69. Radon progeny‏‎ (1 revision)
  70. ICRP Publication 152‏‎ (1 revision)
  71. Reference parameter value‏‎ (1 revision)
  72. ICRP Publication 27‏‎ (1 revision)
  73. ICRP Publication 33‏‎ (1 revision)
  74. Detriment-adjusted risk‏‎ (1 revision)
  75. ICRP Publication 48‏‎ (1 revision)
  76. Dose-response function‏‎ (1 revision)
  77. ICRP Publication 62‏‎ (1 revision)
  78. ICRP Publication 77‏‎ (1 revision)
  79. Supervised area‏‎ (1 revision)
  80. Equilibrium factor‏‎ (1 revision)
  81. Thoron progeny‏‎ (1 revision)
  82. 1950 Recommendations‏‎ (1 revision)
  83. Transgenerational effect‏‎ (1 revision)
  84. Non-homologous end joining‏‎ (1 revision)
  85. Health Surveillance‏‎ (2 revisions)
  86. Basal cell‏‎ (2 revisions)
  87. Branching fraction‏‎ (2 revisions)
  88. Chronic exposure‏‎ (2 revisions)
  89. Radiographer‏‎ (2 revisions)
  90. Colony‏‎ (2 revisions)
  91. Cosmic Radiation in Aviation‏‎ (2 revisions)
  92. Decommissioning‏‎ (2 revisions)
  93. Representative organism (non-human biota)‏‎ (2 revisions)
  94. ICRPædia Guide to the Basics of Ionising Radiation‏‎ (2 revisions)
  95. Dose-threshold‏‎ (2 revisions)
  96. Threshold dose for tissue reactions‏‎ (2 revisions)
  97. Magnetosphere‏‎ (2 revisions)
  98. Fractional absorption in the gastrointestinal tract‏‎ (2 revisions)
  99. Action Level‏‎ (2 revisions)
  100. Heliosphere‏‎ (2 revisions)
  101. Pharynx‏‎ (2 revisions)
  102. Class SR-0 gases‏‎ (2 revisions)
  103. Decontamination‏‎ (2 revisions)
  104. Representative person‏‎ (2 revisions)
  105. Diastasis‏‎ (2 revisions)
  106. Safety‏‎ (2 revisions)
  107. Dose per unit intake coefficient‏‎ (2 revisions)
  108. Specific effective energy‏‎ (2 revisions)
  109. Emergency‏‎ (2 revisions)
  110. Limitation of dose‏‎ (2 revisions)
  111. Exposure, external or internal‏‎ (2 revisions)
  112. Transmission detection system‏‎ (2 revisions)
  113. Multistage tumorigenesis‏‎ (2 revisions)
  114. Non-sphericity parameter‏‎ (2 revisions)
  115. Graft vs host disease‏‎ (2 revisions)
  116. Air-kerma, incident‏‎ (2 revisions)
  117. Procedural values‏‎ (2 revisions)
  118. Broad beam therapy irradiation technique‏‎ (2 revisions)
  119. Class SR-1 gases‏‎ (2 revisions)
  120. Committed effective dose‏‎ (2 revisions)
  121. Cost-benefit analysis‏‎ (2 revisions)
  122. Decontamination factor‏‎ (2 revisions)
  123. Reproductive integrity‏‎ (2 revisions)
  124. Safety case‏‎ (2 revisions)
  125. Slow repair‏‎ (2 revisions)
  126. Dose rate‏‎ (2 revisions)
  127. Isotropic geometry‏‎ (2 revisions)
  128. Emergency exposure situation‏‎ (2 revisions)
  129. Lineal energy‏‎ (2 revisions)
  130. Erythropoietin‏‎ (2 revisions)
  131. Thyroid blocking‏‎ (2 revisions)
  132. Exposure (in the context of inhalation)‏‎ (2 revisions)
  133. Transparency‏‎ (2 revisions)
  134. Fractionation and dose delivery patterns‏‎ (2 revisions)
  135. Waste disposal‏‎ (2 revisions)
  136. Non-targeted effects‏‎ (2 revisions)
  137. Orphan source‏‎ (2 revisions)
  138. Hierarchical tissues‏‎ (2 revisions)
  139. Area monitoring‏‎ (2 revisions)
  140. Planned exposure situation‏‎ (2 revisions)
  141. Benthic‏‎ (2 revisions)
  142. Progenitor cell‏‎ (2 revisions)
  143. Bronchial region‏‎ (2 revisions)
  144. Radiation belt‏‎ (2 revisions - redirect page)
  145. Class SR-2 gases‏‎ (2 revisions)
  146. Committed equivalent dose‏‎ (2 revisions)
  147. Reasonableness‏‎ (2 revisions)
  148. Residual dose‏‎ (2 revisions)
  149. Dichotomous‏‎ (2 revisions)
  150. Safety culture‏‎ (2 revisions)
  151. Solar cosmic radiation‏‎ (2 revisions)
  152. Inhalability‏‎ (2 revisions)
  153. Dose rate effectiveness factor‏‎ (2 revisions)
  154. Spontaneous fission‏‎ (2 revisions)
  155. Itinerant (radiation) worker‏‎ (2 revisions)
  156. Emergency plan‏‎ (2 revisions)
  157. Linear-non-threshold model‏‎ (2 revisions)
  158. Ethics‏‎ (2 revisions)
  159. ALARA‏‎ (2 revisions)
  160. Trapped particles‏‎ (2 revisions)
  161. High level waste‏‎ (2 revisions)
  162. Platelet-derived growth factor‏‎ (2 revisions)
  163. Radiation modifier‏‎ (2 revisions)
  164. Clearance‏‎ (2 revisions)
  165. Radiological protection principles‏‎ (2 revisions)
  166. Deontological Ethics‏‎ (2 revisions)
  167. Respiratory protection‏‎ (2 revisions)
  168. Differentiation‏‎ (2 revisions)
  169. Scintigraphy‏‎ (2 revisions)
  170. Solar cycle‏‎ (2 revisions)
  171. Inner bremsstrahlung‏‎ (2 revisions)
  172. Systemic model‏‎ (2 revisions)
  173. Linear-quadratic dose response model‏‎ (2 revisions)
  174. Time factor‏‎ (2 revisions)
  175. Myocardial perfusion‏‎ (2 revisions)
  176. Activity‏‎ (2 revisions)
  177. What is Radon?‏‎ (2 revisions)
  178. Oversight‏‎ (2 revisions)
  179. Beta-minus decay‏‎ (2 revisions)
  180. Projected dose‏‎ (2 revisions)
  181. Clearance level‏‎ (2 revisions)
  182. Radionuclides of natural origin‏‎ (2 revisions)
  183. Recovery (cellular or tissue)‏‎ (2 revisions)
  184. Retrievability‏‎ (2 revisions)
  185. Immune system‏‎ (2 revisions)
  186. Dose constraint‏‎ (2 revisions)
  187. Institutional control‏‎ (2 revisions)
  188. Early normal tissue responses‏‎ (2 revisions)
  189. Stakeholder‏‎ (2 revisions)
  190. Tachycardia‏‎ (2 revisions)
  191. Tissue equivalent material‏‎ (2 revisions)
  192. Myocardial stress test‏‎ (2 revisions)
  193. Beta-plus decay‏‎ (2 revisions)
  194. Calculating Doses from Intakes of Radionuclides‏‎ (2 revisions)
  195. Radiation safety officer‏‎ (2 revisions)
  196. Radioresponsiveness‏‎ (2 revisions)
  197. Recovery responder‏‎ (2 revisions)
  198. Cumulative dose‏‎ (2 revisions)
  199. Reversibility‏‎ (2 revisions)
  200. In vivo radiobioassay‏‎ (2 revisions)
  201. Dose conversion coefficient‏‎ (2 revisions)
  202. Solar particle event‏‎ (2 revisions)
  203. Edema‏‎ (2 revisions)
  204. Excess relative risk‏‎ (2 revisions)
  205. Exposure situation‏‎ (2 revisions)
  206. Worker‏‎ (2 revisions)
  207. Nuclear track detectors‏‎ (2 revisions)
  208. Growth factor‏‎ (2 revisions)
  209. Alimentary tract transfer factor‏‎ (2 revisions)
  210. Particle radiance‏‎ (2 revisions)
  211. Hormones‏‎ (2 revisions)
  212. Authorization‏‎ (2 revisions)
  213. Protection strategy‏‎ (2 revisions)
  214. Radiation source‏‎ (2 revisions)
  215. Clonogenic cells‏‎ (2 revisions)
  216. Radiosensitiser‏‎ (2 revisions)
  217. Curie‏‎ (2 revisions)
  218. Rehabilitation of living conditions‏‎ (2 revisions)
  219. Right to know‏‎ (2 revisions)
  220. Incidence‏‎ (2 revisions)
  221. Solar wind‏‎ (2 revisions)
  222. Effect Dose 50‏‎ (2 revisions)
  223. Endogeneous excretion‏‎ (2 revisions)
  224. Target tissue‏‎ (2 revisions)
  225. Measuring and Reducing Radon Levels in your Home‏‎ (2 revisions)
  226. Exposure to Radon at Home‏‎ (2 revisions)
  227. GATA binding protein 2‏‎ (2 revisions)
  228. Working level‏‎ (2 revisions)
  229. OLINDA/EXM‏‎ (2 revisions)
  230. Hounsfield unit‏‎ (2 revisions)
  231. Authorized limit‏‎ (2 revisions)
  232. Cardiac arrhythmias‏‎ (2 revisions)
  233. Clonogenic survival‏‎ (2 revisions)
  234. Radiosensitivity, cellular‏‎ (2 revisions)
  235. Cytokines‏‎ (2 revisions)
  236. Rigidity‏‎ (2 revisions)
  237. Security‏‎ (2 revisions)
  238. Incident‏‎ (2 revisions)
  239. Intermediate level waste‏‎ (2 revisions)
  240. Stenosis‏‎ (2 revisions)
  241. Local DRL‏‎ (2 revisions)
  242. Tolerability‏‎ (2 revisions)
  243. Medical exposure‏‎ (2 revisions)
  244. Naturally occurring radioactive material‏‎ (2 revisions)
  245. Acute radiation syndrome‏‎ (2 revisions)
  246. Working level month‏‎ (2 revisions)
  247. Alveolar-interstitial region‏‎ (2 revisions)
  248. Patient entrance reference point‏‎ (2 revisions)
  249. Autoimmune disease‏‎ (2 revisions)
  250. Potential recoverability correction factor‏‎ (2 revisions)

View (previous 250 | next 250) (20 | 50 | 100 | 250 | 500)